AS OF

Sep 27 closing price

Price

$22.88

Change

+$0.15 (+0.66%)

Capitalization

2.46B

32 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

GH Stock GH is expected to report earnings to fall -61% to -74 cents per share on August 01

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

08/01/24

GH - Guardant Health

Q2'24

Est.

$-0.74

Q1'24

Beat

by $0.41

Q4'23

Beat

by $0.22

Q3'23

Beat

by $0.30

Q2'23

Beat

by $0.40

The last earnings report on March 31 showed earnings per share of -46 cents, beating the estimate of -87 cents. P/B Ratio (15.528) is normal, around the industry mean (22.665). P/E Ratio (0.000) is within average values for comparable stocks, (82.398). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.589). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.021) is also within normal values, averaging (51.536). With 977.95K shares outstanding, the current market capitalization sits at 2.46B.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GH (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of diagnostic technologies to improve cancer management

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

Medical Or Nursing Services

Address

3100 Hanover Street

Phone

+1 855 698-8887

Employees

1779

Web

https://www.guardanthealth.com